Leading Proxy Advisory Firms Endorse Land & Buildings' Nominees for National Health Investors Board in Upcoming Shareholder Meeting

Reuters
昨天
Leading Proxy Advisory Firms Endorse Land & Buildings' Nominees for <a href="https://laohu8.com/S/NHI">National Health Investors</a> Board in Upcoming Shareholder Meeting

Ahead of the 2025 Annual Meeting of Stockholders scheduled for May 21, leading independent proxy advisory firms Institutional Shareholder Services Inc. (ISS) and Glass Lewis have both recommended that stockholders of National Health Investors Inc. (NHI) vote in favor of the director nominees proposed by Land & Buildings Investment Management, LLC. The nominees, Jim Hoffmann and Adam Troso, have been endorsed for their independence and relevant experience, which ISS believes are necessary for value-enhancing changes in NHI's boardroom. ISS criticized NHI's current board for its reactive and defensive approach to corporate governance and highlighted concerns over interlocking relationships with National Healthcare Corp. $(NHC.AU)$ affecting profitability. Stockholders are urged by Land & Buildings to support their nominees using the GOLD proxy card.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. National Health Investors Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250512851954) on May 12, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10